These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1162515)

  • 1. Cutaneous reactions to topical application of hydroquinone. Results of a 6-year investigation.
    Bentley-Phillips B; Bayles MA
    S Afr Med J; 1975 Aug; 49(34):1391-5. PubMed ID: 1162515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Depigmentation for cosmetic purposes: prevalence and side-effects in a female population in Senegal].
    Raynaud E; Cellier C; Perret JL
    Ann Dermatol Venereol; 2001; 128(6-7):720-4. PubMed ID: 11460033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroquinone for skin lightening: safety profile, duration of use and when should we stop?
    Tse TW
    J Dermatolog Treat; 2010 Sep; 21(5):272-5. PubMed ID: 20095963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achromic patch test from hydroquinone monobenzyl ether.
    Sanz de Galdeano C; Aguirre A; Zabala R; Ratón JA; Díaz-Pérez JL
    Contact Dermatitis; 1993 Jul; 29(1):43-4. PubMed ID: 8365157
    [No Abstract]   [Full Text] [Related]  

  • 5. Q-Switched Alexandrite Laser and Topical 20% Monobenzyl Ester of Hydroquinone Removal of Tacrolimus-Induced Repigmentation (After Complete Depigmentation With 20% Monobenzyl Ether of Hydroquinone).
    McGuinn KP; Saedi N; Green JB; Dover JS
    Dermatol Surg; 2019 May; 45(5):756-757. PubMed ID: 30893165
    [No Abstract]   [Full Text] [Related]  

  • 6. Ochronosis following skin bleaching with hydroquinone.
    Findlay GH
    J Am Acad Dermatol; 1982 Jun; 6(6):1092-3. PubMed ID: 7096673
    [No Abstract]   [Full Text] [Related]  

  • 7. Aesthetic problems associated with the cosmetic use of bleaching products.
    Ly F; Soko AS; Dione DA; Niang SO; Kane A; Bocoum TI; Dieng MT; Ndiaye B
    Int J Dermatol; 2007 Oct; 46 Suppl 1():15-7. PubMed ID: 17919199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complications of cosmetic skin bleaching in Africa].
    Morand JJ; Ly F; Lightburn E; Mahé A
    Med Trop (Mars); 2007 Dec; 67(6):627-34. PubMed ID: 18300529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monobenzone, Superfade, vitiligo and confetti-like depigmentation.
    Catona A; Lanzer D
    Med J Aust; 1987 Mar; 146(6):320-1. PubMed ID: 3821640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monobenzylether of hydroquinone.
    Bentley-Phillips B
    Br J Dermatol; 1978 Dec; 99(6):719. PubMed ID: 737135
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized and placebo-controlled study to compare the skin-lightening efficacy and safety of lignin peroxidase cream vs. 2% hydroquinone cream.
    Mauricio T; Karmon Y; Khaiat A
    J Cosmet Dermatol; 2011 Dec; 10(4):253-9. PubMed ID: 22151932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cosmetic and dermatology: bleaching creams.
    Engasser PG; Maibach HI
    J Am Acad Dermatol; 1981 Aug; 5(2):143-7. PubMed ID: 7021611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
    Adalatkhah H; Sadeghi-Bazargani H
    Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pigmented contact dermatitis secondary to benzyl salicylate.
    Alagappan U; Tay YK; Lim SP
    Acta Derm Venereol; 2013 Sep; 93(5):590. PubMed ID: 23529141
    [No Abstract]   [Full Text] [Related]  

  • 15. Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams.
    Findlay GH; Morrison JG; Simson IW
    Br J Dermatol; 1975 Dec; 93(6):613-22. PubMed ID: 1220808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal.
    Mahé A; Ly F; Aymard G; Dangou JM
    Br J Dermatol; 2003 Mar; 148(3):493-500. PubMed ID: 12653741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cosmetic use of skin depigmentation products in Africa].
    Del Giudice P; Raynaud E; Mahé A
    Bull Soc Pathol Exot; 2003 Jan; 96(5):389-93. PubMed ID: 15015845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroquinone-induced exogenous ochronosis in Chinese--two case reports and a review.
    Tan SK; Sim CS; Goh CL
    Int J Dermatol; 2008 Jun; 47(6):639-40. PubMed ID: 18477169
    [No Abstract]   [Full Text] [Related]  

  • 19. Exogenous ochronosis in a Mexican-American woman.
    Howard KL; Furner BB
    Cutis; 1990 Mar; 45(3):180-2. PubMed ID: 2311433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening.
    Draelos ZD; Yatskayer M; Bhushan P; Pillai S; Oresajo C
    Cutis; 2010 Sep; 86(3):153-8. PubMed ID: 21049734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.